Cocrystal Pharma Inc (COCP)

Cocrystal Pharma Inc (COCP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $20.8M; returns 1 day +4.2%, 1 week -6.9%, 1 year -10.4%.

Cocrystal Pharma Inc. (COCP) is a clinical-stage biotechnology company dedicated to the discovery and development of novel antiviral therapeutics. The company's business model is centered on leveraging its unique structure-based drug discovery platform and Nobel Prize-winning expertise to create small-molecule antiviral drugs that target the replication processes of various viruses.

Groups COCP belongs to

• Clinical Stage Biotech
• Antivirals
• Biotechnology
• Drug Discovery
• Infectious Diseases
• Healthcare
• Biopharmaceutical
• Life Sciences
• Clinical Stage
• COVID-19

COCP financial model: income statement, cash flow and balance sheet